Huaizhong Health Group, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statement of Cash Flows

In USD, except per-share amounts

	FY2022 12 months to Oct 31, 2022	FY2021 12 months to Oct 31, 2021	FY2020 12 months to Oct 31, 2020	FY2019 12 months to Oct 31, 2019	FY2018 12 months to Oct 31, 2018
Changes in assets and liabilities
Increase (Decrease) in accrued expenses
Depreciation expense
Write off of fixed assets , net
Issuance of shares as equity compensation (related party)
Net loss
Changes in current assets and liabilities:
Related party advances funding operations
Stock based compensation - related party
Accounts payable
Prepaid expenses
Accounts payable and accrued liabilities
Net cash used in operating activities
Net change in cash for the year
Cash at beginning of period
Cash at end of period
CASH FLOWS FROM FINANCING ACTIVITIES
Loans received from a related party
Net cash provided for by financing activities
Net cash (used in) provided by investing activities
Net (Decrease) in Cash
Cash at the beginning of the period
Cash at the end of the period
Cash paid for income taxes
Issuance of common stock as equity compensation - former related party
Issuance of common stock for conversion of convertible note- related party
Convertible note issued for settlement of due to related party
Forgiveness of due to related party
Forgiveness of convertible note payable and accrued interest - related party
Related party advances funding operations
Net cash provided by financing activities
Net change in cash for the period
Cash at beginning of period
Cash at end of period
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes
Cash paid for interest
Issuance of shares as equity compensation (related party)
Conversion of loans into equity (related party)

Comments